{"id":6017,"date":"2026-10-16T12:43:09","date_gmt":"2026-10-16T17:43:09","guid":{"rendered":"https:\/\/directsourcenews.org\/index.php\/2026\/10\/16\/azitra-aztr-announces-1-for-10-reverse-stock-split\/"},"modified":"2026-10-16T12:43:12","modified_gmt":"2026-10-16T17:43:12","slug":"azitra-aztr-announces-1-for-10-reverse-stock-split","status":"publish","type":"post","link":"https:\/\/directsourcenews.org\/index.php\/2026\/10\/16\/azitra-aztr-announces-1-for-10-reverse-stock-split\/","title":{"rendered":"Azitra (AZTR) Announces 1-for-10 Reverse Stock Split"},"content":{"rendered":"<p> BRANFORD, CT \u2013 October 16, 2026 (STL.News) Azitra Inc. (NYSE American: AZTR), a clinical-stage biotechnology company developing treatments for dermatological conditions, announced Friday that it will implement a 1-for-10 reverse stock split, reducing its issued common shares from approximately 60.6 million to 6.06 million. The transaction is scheduled to become effective at 12:01 a.m. Eastern Time on October 26, 2026. Azitra shares will begin trading on a split-adjusted basis when the NYSE American opens that morning, retaining the existing ticker symbol AZTR. The decision represents a significant change in the company\u2019s capital structure. Although the transaction will reduce the<\/p>\n<p><strong>Source:<\/strong> <a href=\"https:\/\/www.stl.news\/azitra-aztr-announces-1-for-10-reverse-stock-split\/\" target=\"_blank\" rel=\"nofollow noopener\">Read Original Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>BRANFORD, CT \u2013 October 16, 2026 (STL.News) Azitra Inc. (NYSE American: AZTR), a clinical-stage biotechnology company developing treatments for dermatological conditions, announced Friday that it will implement a 1-for-10 reverse stock split, reducing its issued common shares from approximately 60.6&#8230; <\/p>\n","protected":false},"author":1,"featured_media":6018,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-6017","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"_links":{"self":[{"href":"https:\/\/directsourcenews.org\/index.php\/wp-json\/wp\/v2\/posts\/6017","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/directsourcenews.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/directsourcenews.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/directsourcenews.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/directsourcenews.org\/index.php\/wp-json\/wp\/v2\/comments?post=6017"}],"version-history":[{"count":1,"href":"https:\/\/directsourcenews.org\/index.php\/wp-json\/wp\/v2\/posts\/6017\/revisions"}],"predecessor-version":[{"id":6019,"href":"https:\/\/directsourcenews.org\/index.php\/wp-json\/wp\/v2\/posts\/6017\/revisions\/6019"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/directsourcenews.org\/index.php\/wp-json\/wp\/v2\/media\/6018"}],"wp:attachment":[{"href":"https:\/\/directsourcenews.org\/index.php\/wp-json\/wp\/v2\/media?parent=6017"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/directsourcenews.org\/index.php\/wp-json\/wp\/v2\/categories?post=6017"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/directsourcenews.org\/index.php\/wp-json\/wp\/v2\/tags?post=6017"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}